Potency of propofol for inducing loss of consciousness in end-stage kidney disease patients.
It can be difficult for anesthesiologists to determine the optimal dose of propofol for end-stage kidney disease (ESKD) patients due to changes in drug disposition. The purpose of this study was to evaluate the potency of propofol for inducing loss of consciousness in ESKD patients. Patients with no...
Guardado en:
Autores principales: | Mi Roung Jun, Mun Gyu Kim, Ki Seob Han, Ji Eun Park, Ho Bum Cho, Sun Young Park, Sanghoon Song, Jae Hwa Yoo, Ji Won Chung, Sang Ho Kim |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a01af8907d5940c083dcba43ad5fffa8 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The influence of propofol-based total intravenous anesthesia on postoperative outcomes in end-stage renal disease patients: A retrospective observation study.
por: Ho Bum Cho, et al.
Publicado: (2021) -
Nationwide Glaucoma incidence in end stage renal disease patients and kidney transplant recipients
por: Jong Joo Moon, et al.
Publicado: (2021) -
Dynamic change of global and local information processing in propofol-induced loss and recovery of consciousness.
por: Martin M Monti, et al.
Publicado: (2013) -
Impact of kidney transplantation on the risk of retinal vein occlusion in end-stage renal disease
por: Jangwook Lee, et al.
Publicado: (2021) -
Establishment of HLA class I and MICA/B null HEK-293T panel expressing single MICA alleles to detect anti-MICA antibodies
por: Ji-Ho Jeon, et al.
Publicado: (2021)